Sage Journals: Discover world-class research

Retricted access

Research article

First published 2005-08

Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis

Robert M Herndon, Richard A Rudick, Frederick E Munschauer [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2007-5

Development of neutralizing antibodies to intramuscular interferon beta-1a (Avonex ®)

Suzan E. Goelz, L. Walt

Multiple Sclerosis Journal

Retricted access

Research article

First published 2005-10

Economic evaluation of Avonex® (interferon beta-1a) in patients following a single demyelinating event

Michael Iskedjian, John H Walker, Trevor Gray [...]

Multiple Sclerosis Journal

Free access

Other

First published 2010-01

A randomized,blinded,parallel-group,pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis

Elliot M. Frohman, Gary Cutter, Gina Remington [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2002-02

Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-1a (AVONEX®) therapy

J Reeß, J Haas, K Gabriel [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025

Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry

Melissa A Wright, Bradley J Barney, Skyler Peterson [...]

Journal of Child Neurology

Retricted access

Other

First published 2006-09

Serum immunologic markers in multiple sclerosis patients on continuous combined therapy with beta-interferon 1a,prednisone and azathioprine

C A Braun Hashemi, Y CQ Zang, J A Arbona [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 1996-06

Interferon beta treatment for multiple sclerosis: persisting questions

Donald E Goodkin

Multiple Sclerosis Journal

Open access

Review article

First published 2012

Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine

Teri L. Schreiner, Augusto Miravalle

Journal of Central Nervous System Disease

Retricted access

Research article

First published 2004-10

An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis

T L Vollmer, J T Phillips, A D Goodman [...]

Multiple Sclerosis Journal

Search results